Great Valley Advisor Group, Inc. Biogen Inc. Transaction History
Great Valley Advisor Group, Inc.
- $3.84 Billion
- Q3 2024
A detailed history of Great Valley Advisor Group, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Great Valley Advisor Group, Inc. holds 3,229 shares of BIIB stock, worth $460,261. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,229
Previous 3,489
7.45%
Holding current value
$460,261
Previous $808,000
22.65%
% of portfolio
0.02%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding BIIB
# of Institutions
993Shares Held
130MCall Options Held
1.12MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.39 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$2.29 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.07 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.05 Billion0.06% of portfolio
-
Jpmorgan Chase & CO New York, NY5.26MShares$749 Million0.08% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $20.5B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...